Back to All Events

Trial by Data: Efficacy and Safety Across Today’s Pharmacologic Presbyopia Drops

 
 

Presbyopia is a condition that affects nearly everyone over the age of 45. Traditional treatment options like eyeglasses and contact lenses are not ideal options for all patients. Recently pharmacologic options have come to the market. This lecture will review and update the pharmacologic treatment options for presbyopia.

Feedback from anonymous survey:

  • I really enjoyed this lecture and how the presenters explained the research data in an easy to understand way!

  • Well organized ce. Enjoyed it.

  • Love the comparison between the drops and the two speakers.

  • Exceptional presentation. Well presented.

  • Thank you for an informative CE!

  • Gina & Nate are great presenters, timely topic, can use immediately in practice.

  • Love the readily available handouts. The webinar platform is easy to access.

Speakers: Dr. Nathan Lighthizer and Dr. Gina Wesley

Moderator: Dr. Jennifer Stewart

COPE ID: 101598-PH

Category: Pharmacology

Thank you to Orasis Pharmaceuticals for exhibiting at this event.

This event is undergoing COPE approval for 1 hour of CE credit.

Handout
Previous
Previous
December 11

Updates in Keratoconus Research: Present and Future

Next
Next
December 18

Contact Lens Complications in the Primary Care Setting: A Lens-by-Lens Approach